Log In
Print this Print this

TKM-PLK1 (PLK1424) (TKM-080301) (formerly PLK1 SNALP)

  Manage Alerts
Collapse Summary General Information
Company Arbutus Biopharma Corp.
DescriptionLipid nanoparticle encapsulated small interfering RNA (siRNA) targeting polo-like kinase 1 (PLK1; STPK13)
Molecular Target Polo-like kinase 1 (PLK1) (STPK13)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today